| Descriptor English: | Abiraterone Acetate | ||||
| Descriptor Spanish: |
Acetato de Abiraterona
| ||||
| Descriptor Portuguese: | Acetato de Abiraterona | ||||
| Descriptor French: | Acétate d'abiratérone | ||||
| Entry term(s): |
17-(3-pyridyl)-5,16-androstadien-3beta-acetate CB 7630 CB-7630 CB7630 Zytiga |
||||
| Tree number(s): |
D04.210.500.054.079.065 |
||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000069501 | ||||
| Scope note: | An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER. |
||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
| Pharm Action: |
Antineoplastic Agents Steroid Synthesis Inhibitors Cytochrome P-450 Enzyme Inhibitors |
||||
| Registry Number: | EM5OCB9YJ6 | ||||
| Public MeSH Note: | 2016; ABIRATERONE ACETATE was indexed under ANDROSTENES 1994-2015 |
||||
| History Note: | 2016 (1994) |
||||
| DeCS ID: | 55939 | ||||
| Unique ID: | D000069501 | ||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
| Date Established: | 2016/01/01 | ||||
| Date of Entry: | 2015/07/09 | ||||
| Revision Date: | 2016/05/27 |
-
-
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds
|
|
Abiraterone Acetate
- Preferred
17-(3-pyridyl)-5,16-androstadien-3beta-acetate
- Narrower
Zytiga
- Narrower
CB 7630
- Narrower
| Concept UI |
M0562608 |
| Scope note | An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER. |
| Preferred term | Abiraterone Acetate |
| Concept UI |
M0237234 |
| Preferred term | 17-(3-pyridyl)-5,16-androstadien-3beta-acetate |
| Concept UI |
M0579770 |
| Preferred term | Zytiga |
| Concept UI |
M0237237 |
| Preferred term | CB 7630 |
| Entry term(s) |
CB-7630 CB7630 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey